By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Lobe Sciences Ltd.

Lobe Sciences Ltd. (LOBEF)

OTC Market Data in USD, Fundamentals in CAD
$0.03
$0.00
+5.92%
Last Update: 3 Sept 2025, 16:34
$6.57M
Market Cap
-1.28
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.03
52 Week Range

LOBEF Stock Price Chart

Explore Lobe Sciences Ltd. interactive price chart. Choose custom timeframes to analyze LOBEF price movements and trends.

LOBEF Company Profile

Discover essential business fundamentals and corporate details for Lobe Sciences Ltd. (LOBEF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

24 Aug 2023

Employees

CEO

Frederick Dominick Sancilio

Description

Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

LOBEF Financial Timeline

Browse a chronological timeline of Lobe Sciences Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 Dec 2026

Upcoming earnings on 27 Apr 2026

Upcoming earnings on 26 Jan 2026

Earnings released on 24 Jul 2025

Earnings released on 28 Apr 2025

EPS came in at -$0.00 .

Earnings released on 13 Feb 2025

EPS came in at -$0.00 .

Earnings released on 28 Jan 2025

EPS came in at -$0.01 .

Earnings released on 26 Jul 2024

EPS came in at -$0.00 .

Earnings released on 29 Apr 2024

EPS came in at -$0.01 , while revenue for the quarter reached $50.16K .

Earnings released on 20 Feb 2024

EPS came in at -$0.01 , while revenue for the quarter reached $100.46K .

Earnings released on 11 Sept 2023

EPS came in at -$0.01 , while revenue for the quarter reached $620.09K .

Earnings released on 1 Aug 2023

EPS came in at -$0.00 .

Earnings released on 28 Apr 2023

EPS came in at -$0.01 .

Earnings released on 30 Jan 2023

EPS came in at -$0.05 .

Earnings released on 30 Nov 2022

EPS came in at -$0.02 .

Stock split effective on 9 Jun 2022

Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 May 2022

EPS came in at -$0.25 .

Earnings released on 28 Feb 2022

EPS came in at -$0.07 .

Earnings released on 30 Nov 2021

EPS came in at -$0.10 .

Earnings released on 31 Aug 2021

EPS came in at -$0.35 .

Earnings released on 31 May 2021

EPS came in at $1.60 .

Earnings released on 28 Feb 2021

EPS came in at -$0.07 .

Earnings released on 30 Nov 2020

EPS came in at -$0.04 , while revenue for the quarter reached $140.39K .

LOBEF Stock Performance

Access detailed LOBEF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run